Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2025-12-01 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于回购股份进展的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company about the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with regulatory rules. The text references specific dates and regulatory guidelines related to share buybacks. The document is relatively short (1258 characters) and focuses on the update of the share repurchase activity rather than a full financial report or earnings release. This matches the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2025-12-01 Chinese
关于补缴税款的公告
Regulatory Filings Classification · 92% confidence The document is a formal announcement by the company’s board regarding the supplementary payment of previously received preferential income taxes and associated late fees. It does not contain actual financial statements or detailed period results; it is not a call transcript, earnings release, management report, AGM material, proxy solicitation, M&A filing, or any of the other specific categories. It is a routine regulatory announcement about tax compliance. Therefore it falls under Regulatory Filings (fallback category).
2025-11-27 Chinese
关于回购股份进展的公告
Transaction in Own Shares Classification · 93% confidence The document is an announcement of the company’s share repurchase progress, including actual quantities, prices, and compliance with regulatory repurchase rules. This matches the description for Transaction in Own Shares (Code: POS), which covers share buyback reports. Therefore, the correct classification is POS.
2025-11-03 Chinese
中国国际金融股份有限公司关于重药控股股份有限公司收购报告书之2025年度第三季度持续督导意见
Capital/Financing Update Classification · 95% confidence The document is titled as a "2025 Third Quarter Continuous Supervision Opinion" related to an acquisition report for a listed company. It references regulatory rules about acquisition exemptions, details about share transfers, and ongoing compliance and governance matters during the acquisition process. The document is issued by a financial advisor and provides an opinion on the acquisition progress and compliance rather than presenting full financial statements or quarterly financial results. It is not a full quarterly report but a supervisory opinion related to an acquisition report. This fits best under the category of Capital/Financing Update (CAP), as it deals with acquisition progress, shareholding changes, and related regulatory compliance during a capital transaction. The document length is under 5,000 characters, but it contains substantive content beyond a mere announcement, so it is not a Report Publication Announcement (RPA). Therefore, the classification is CAP with high confidence.
2025-10-29 Chinese
关于挂牌转让重庆化医控股集团财务有限公司20%股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the transfer of a 20% equity stake in a subsidiary company (Chongqing Huayi Holding Group Financial Co., Ltd.) by Zhongyao Holdings Co., Ltd. It includes comprehensive information about the related parties, the transaction details, financial data of the involved entities, regulatory approvals required, and board resolutions. The content focuses on a specific capital transaction involving related parties and the transfer of shares. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive disclosure about a capital transaction and related party dealings. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including share transfers and related party transactions.
2025-10-27 Chinese
第九届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 19th meeting of the 9th Board of Directors of the company. It includes details about the meeting date, attendance, and voting results on specific agenda items, such as approval of the 2025 third quarter report and a related party transaction. The document does not contain the full quarterly report itself but references it as disclosed separately on the same day. The content focuses on board meeting decisions and approvals, which aligns with Board/Management Information filings. The document length is short (658 characters), and it is clearly an announcement of board resolutions rather than the report itself or a detailed financial report. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-10-27 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.